Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 23 hours ago

Indications

Ibandronic Acid & Calcium Orotate is used to treat and prevent osteoporosis in women, especially after menopause, and in men. It raises bone mineral density (BMD) and lowers the number of vertebral fractures.

⚠️ Always consult a registered physician before taking any medicine.

Pregnancy & Breastfeeding

There are no adequate and well-controlled studies of this kit (Ibandronic Acid & Calcium Orotate) in pregnant women. So it should be used during pregnancy only if the likely benefit justifies the possible risk to the mother and the fetus. It isn't known whether the kit passes into human milk, and for that reason caution is needed when it is given to a nursing woman.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: The recommended dose of Ibandronic Acid is one 150 mg tablet once a month, on the same date each month. To get the full clinical benefit, two Calcium Orotate tablets a day are usually recommended, taken in divided doses. Take the Ibandronic Acid tablet from this Kit at least 60 minutes before the first food or drink of the day (plain water is fine) and before any oral medicine or supplement, including calcium, antacids or vitamins. This gives better absorption and clinical benefit. Swallow the tablet whole with a full glass of plain water (250 ml) while standing or sitting upright. That helps it reach the stomach and lowers the chance of irritation of the oesophagus. The patient should not lie down for 60 minutes after taking the tablet. The 150 mg tablet should always be taken on the same date each month, which is the patient's Ibandronic Acid day. If the monthly dose is missed and the next scheduled Ibandronic Acid day is more than 7 days away, the patient should take one Ibandronic Acid 150 mg tablet in the morning after the day they remember. After that, they go back to one tablet every month, in the morning of their chosen day, following the original schedule. If the next scheduled Ibandronic Acid day is only 1 to 7 days away, the patient must wait and take the tablet on the scheduled day of the following month. Then they return to one 150 mg tablet every month, in the morning of their chosen day, according to the original schedule. The patient must not take two Ibandronic Acid 150 mg tablets within the same week. Start the Calcium Orotate tablets on the day after the Ibandronic Acid day (from day-2 and onwards).

Side Effects & Interactions